Life sciences · Journal article

What’s in a Name? The Rise of Klebsiella pneumoniae: From Friedländer to Klebs

Cmi Communications · August 1, 2026

Expert Guidance Why this matters to you Expert discussion

A consensus or society position rather than new primary data.

AI Summary

This is a narrative historical review documenting the clinical evolution of Klebsiella pneumoniae from its first description in 1882 as a cause of fatal community-acquired pneumonia to its current role as a major healthcare-associated pathogen and driver of antimicrobial resistance. The source provides historical context and expert perspective rather than original primary data or systematic evidence synthesis.

What was studied

Journal article. Klebsiella pneumoniae as a pathogen species across clinical settings (community-acquired and healthcare-associated infections).

Key findings

K. pneumoniae first described in 1882 as an encapsulated bacillus causing fatal community-acquired pneumonia Species has evolved into a major cause of healthcare-associated infections (HAIs) and global antimicrobial resistance driver

Safety

No quantitative epidemiological data (incidence, prevalence, mortality rates) provided

Who this may help

This review offers historical context on the emergence and epidemiological shift of K. pneumoniae but does not provide quantitative clinical outcome data, treatment efficacy comparisons, or risk stratification tools to guide current clinical decision-making.

Plain-language summary

A narrative historical review of Klebsiella pneumoniae's clinical evolution and epidemiology, presenting expert perspective rather than primary research evidence or a systematic synthesis.

Reported figures

Quoted from the source exactly as published.

First description year1882

Clinical bottom line

Caveats

No quantitative epidemiological data (incidence, prevalence, mortality rates) provided
No comparison of treatment outcomes or resistance rates across time periods with numeric values
No systematic review methodology; source selection and evidence synthesis methods not stated
Title and opening text suggest a historical narrative rather than evidence synthesis of clinical outcomes

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Study design

insufficient

Historical narrative review; no experimental or observational study design employed.

Directness

moderate

Addresses clinical evolution and epidemiology of K. pneumoniae directly but lacks quantitative outcome data.

Consistency

insufficient

Single source; no comparison to other reviews or synthesis of conflicting evidence reported.

Risk of bias

insufficient

Narrative review format; no discussion of source selection criteria or bias assessment methods.

Sample adequacy

insufficient

No quantitative sample; literature-based historical synthesis without enumeration of sources.

Source abstract

Within the family of Enterobacteriaceae, few species have evolved in parallel with the history of clinical microbiology and infectious diseases as closely as Klebsiella pneumoniae. First described in 1882 as an encapsulated bacillus causing fatal community-acquired pneumonia (CAP),[1] it has since evolved into a major cause of healthcare-associated infections (HAIs) and a global driver of antimicrobial resistance (AMR), reflecting a profound transformation in its clinical identity over more than a century[2,3].

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.

Brad SpellbergBassam Ghanem